路透3月11日 - 默克公司（Merck MRK.N）被指控在预防宫颈癌和其他致命癌症的疫苗加德信（Gardasin）的风险问题上隐瞒了事实，一名联邦法官作出了有利于默克公司的判决。
美国北卡罗来纳州夏洛特地区法官肯尼斯-贝尔（Kenneth Bell）周二公布了这一裁决。
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.